Holen Sie sich die Stockscreener-App
257.85
1.91%
4.83
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$253.02
Offen:
$262.52
24-Stunden-Volumen:
1.60M
Relative Volume:
0.85
Marktkapitalisierung:
$31.01B
Einnahmen:
$123.11B
Nettoeinkommen (Verlust:
$1.58B
KGV:
19.79
EPS:
13.0294
Netto-Cashflow:
$2.44B
1W Leistung:
+4.92%
1M Leistung:
-2.68%
6M Leistung:
+13.51%
1J Leistung:
-8.91%
1-Tages-Spanne:
$256.14
$264.80
1-Wochen-Bereich:
$238.81
$264.80
52-Wochen-Spanne:
$206.87
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
257.85 | 30.43B | 123.11B | 1.58B | 2.44B | 13.03 |
|
UNH
Unitedhealth Group Inc
|
330.91 | 302.09B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
75.63 | 97.43B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
330.75 | 74.11B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
265.44 | 71.70B | 268.22B | 6.55B | 7.44B | 22.67 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana, Mark Cuban in Talks on Potential Pharmacy Partnership to Simplify Drug Access - Digital Health News
Humana (HUM) Upgraded to Buy by Jefferies on Strong Growth Prosp - GuruFocus
Humana raised to Buy at Jefferies on Medicare Advantage diversification strategy (HUM:NYSE) - Seeking Alpha
Jefferies Upgrades Humana (HUM): Raises Price Target to $313 | H - GuruFocus
Humana (NYSE:HUM) Has Announced A Dividend Of $0.885 - Yahoo Finance
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885 - simplywall.st
Invesco Ltd. Trims Stock Holdings in Humana Inc. $HUM - MarketBeat
Analyst recommendations: Humana, Newmont, Robert Half, Apple, Macy's… - marketscreener.com
Dodge & Cox Acquires 597,705 Shares of Humana Inc. $HUM - MarketBeat
Is Humana Inc. stock positioned for digital transformationJuly 2025 Final Week & Low Drawdown Trading Strategies - Newser
Humana (HUM) and Mark Cuban Explore Partnership to Simplify Drug Supply Chain - GuruFocus
Humana, Mark Cuban potentially teaming up for pharmacy partnership - Seeking Alpha
Mark Cuban's Cost Plus Drugs, Humana exploring partnership to tackle employer drug costs - Fierce Healthcare
Humana working with Mark Cuban on potential pharmacy partnership - Modern Healthcare
Humana Working With Mark Cuban on Potential Pharmacy Partnership - Bloomberg.com
Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings - 富途牛牛
How Is Humana Stock Performance Compared to Other Healthcare Services Stocks? - Yahoo Finance
Mackenzie Financial Corp Grows Position in Humana Inc. $HUM - MarketBeat
Can Humana Inc. stock beat analyst consensusAnalyst Downgrade & Long Hold Capital Preservation Tips - Newser
Why Humana Inc. stock is a strong buy call2025 AllTime Highs & Safe Capital Growth Tips - Newser
Best Dental Insurance Plans of 2025 - money.com
Humana Inc. stock outperforms competitors on strong trading day - MSN
How Epic, Humana are automating insurance verification - TechTarget
Panagora Asset Management Inc. Purchases 117,580 Shares of Humana Inc. $HUM - MarketBeat
Berman Tabacco Announces Investigation of SelectQuote, Inc. (NYSE:SLQT) - GlobeNewswire Inc.
Berman Tabacco Announces Investigation of Humana, Inc. (NYSE:HUM) - GlobeNewswire
New Insurance Coverage Resource Released by Muse Treatment Exploring Humana Inpatient Rehab Benefits - The Herald-Mail
Wealthedge Investment Advisors LLC Takes $1.29 Million Position in Humana Inc. $HUM - MarketBeat
OMERS ADMINISTRATION Corp Purchases 7,700 Shares of Humana Inc. $HUM - MarketBeat
Skandinaviska Enskilda Banken AB publ Sells 1,200 Shares of Humana Inc. $HUM - MarketBeat
Norges Bank Invests $397.08 Million in Humana Inc. $HUM - MarketBeat
Humana Inc. $HUM Stock Position Lifted by Edgestream Partners L.P. - MarketBeat
Humana Inc. Stock Outperforms Competitors Despite Losses On The Day - 富途牛牛
Humana appeals Medicare Advantage star ratings loss to 5th Circuit - Healthcare Dive
Humana Inc. (HUM) Reaffirms 2025 Earnings Guidance - GuruFocus
Humana (HUM) Reaffirms 2025 Earnings Guidance in December Meetin - GuruFocus
Humana Reaffirms Earnings Guidance for December 2025 - TipRanks
Humana reaffirms 2025 earnings guidance ahead of investor meetings - StreetInsider
Humana Inc Reaffirms 2025 Earnings Guidance - TradingView
Humana (NYSE: HUM) reiterates FY 2025 GAAP EPS $12.26 and adjusted EPS $17.00 - Stock Titan
Korea Investment CORP Sells 5,447 Shares of Humana Inc. $HUM - MarketBeat
Quadrant Capital Group LLC Grows Stake in Humana Inc. $HUM - MarketBeat
Hsbc Holdings PLC Decreases Stock Position in Humana Inc. $HUM - MarketBeat
Groupama Asset Managment Invests $1.16 Million in Humana Inc. $HUM - MarketBeat
Neuberger Berman Group LLC Sells 3,516 Shares of Humana Inc. $HUM - MarketBeat
Boston Partners Sells 717,384 Shares of Humana Inc. $HUM - MarketBeat
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, L - The National Law Review
Local Spotlight: Pick a Medicare Advantage Plan, Here's What to Consider - ABC7 Chicago
Humana Inc. $HUM Shares Bought by Quadrature Capital Ltd - MarketBeat
Crake Asset Management LLP Makes New Investment in Humana Inc. $HUM - MarketBeat
Ceredex Value Advisors LLC Acquires Shares of 71,650 Humana Inc. $HUM - MarketBeat
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):